Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM182732![]() (US9145408, 405) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | n/a | n/a | 0.550 | n/a | n/a | 7.4 | 4 |
Purdue Pharma LP US Patent | Assay Description ORL-1 Receptor [35S]GTPγS Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like (ORL-1) (... | US Patent US9145408 (2015) BindingDB Entry DOI: 10.7270/Q2DJ5DD3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220366![]() (US9290488, B34a) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.24 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220363![]() (US9290488, B20a(i)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.62 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM97710![]() (US8476271, 16 | US9145408, 362) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | n/a | n/a | 4.03 | n/a | n/a | 7.4 | 4 |
Purdue Pharma LP US Patent | Assay Description ORL-1 Receptor [35S]GTPγS Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like (ORL-1) (... | US Patent US9145408 (2015) BindingDB Entry DOI: 10.7270/Q2DJ5DD3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220379![]() (US9290488, L29b) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.20 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220383![]() (US9290488, ZA04) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.84 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220361![]() (US9290488, B11a(ii)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.54 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220376![]() (US9290488, K29b) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.24 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220365![]() (US9290488, B21a) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.80 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220362![]() (US9290488, B12a) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.14 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220378![]() (US9290488, L2b(ii)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 12 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220375![]() (US9290488, K2b(ii)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 14.3 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220377![]() (US9290488, L2b(i)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 14.6 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220360![]() (US9290488, B11a(i)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 16.2 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220373![]() (US9290488, E54a) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 21.7 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220386![]() (US9290488, ZA07) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 22.9 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220381![]() (US9290488, ZA02) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 24.2 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220384![]() (US9290488, ZA05) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 24.5 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220387![]() (US9290488, ZA08) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 29.3 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220374![]() (US9290488, H3a) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 40.1 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220357![]() (US9290488, A11a(ii)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 42.5 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220364![]() (US9290488, B20a(ii)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 51.1 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM97711![]() (US8476271, 17 | US8846929, 360 | US8846929, 361 | ...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | n/a | n/a | 57.2 | n/a | n/a | 7.4 | 4 |
Purdue Pharma LP US Patent | Assay Description ORL-1 Receptor [35S]GTPγS Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like (ORL-1) (... | US Patent US9145408 (2015) BindingDB Entry DOI: 10.7270/Q2DJ5DD3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220359![]() (US9290488, B2a(ii)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 61.3 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM97712![]() (US8476271, 18 | US8846929, 358 | US9145408, 358) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | n/a | n/a | 62.6 | n/a | n/a | 7.4 | 4 |
Purdue Pharma LP US Patent | Assay Description ORL-1 Receptor [35S]GTPγS Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like (ORL-1) (... | US Patent US9145408 (2015) BindingDB Entry DOI: 10.7270/Q2DJ5DD3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220371![]() (US9290488, E53a(i)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 65.7 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220372![]() (US9290488, E53a(ii)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 130 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220356![]() (US9290488, A11a(i)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 139 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220368![]() (US9290488, C20a(ii)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 146 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM199350![]() (US9221831, 15) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 261 | n/a | n/a | 7.4 | 50 |
Purdue Pharma LP US Patent | Assay Description Functional [35S]GTPgammaS binding assays were conducted as follows. ORL-1 membrane solution was prepared by sequentially adding final concentrations ... | US Patent US9221831 (2015) BindingDB Entry DOI: 10.7270/Q2T72G8M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220358![]() (US9290488, B2a(i)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 319 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM182734![]() (US9145408, 369) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | n/a | n/a | 545 | n/a | n/a | 7.4 | 4 |
Purdue Pharma LP US Patent | Assay Description ORL-1 Receptor [35S]GTPγS Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like (ORL-1) (... | US Patent US9145408 (2015) BindingDB Entry DOI: 10.7270/Q2DJ5DD3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM97715![]() (US8476271, 96 | US8846929, 356 | US9145408, 356) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | n/a | n/a | 686 | n/a | n/a | 7.4 | 4 |
Purdue Pharma LP US Patent | Assay Description ORL-1 Receptor [35S]GTPγS Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like (ORL-1) (... | US Patent US9145408 (2015) BindingDB Entry DOI: 10.7270/Q2DJ5DD3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM199363![]() (US9221831, 28) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.22E+3 | n/a | n/a | 7.4 | 50 |
Purdue Pharma LP US Patent | Assay Description Functional [35S]GTPgammaS binding assays were conducted as follows. ORL-1 membrane solution was prepared by sequentially adding final concentrations ... | US Patent US9221831 (2015) BindingDB Entry DOI: 10.7270/Q2T72G8M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM4203![]() (US8530494, 6 | US9221831, 10) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | n/a | n/a | 1.64E+3 | n/a | n/a | 7.4 | 50 |
Purdue Pharma LP US Patent | Assay Description Functional [35S]GTPgammaS binding assays were conducted as follows. ORL-1 membrane solution was prepared by sequentially adding final concentrations ... | US Patent US9221831 (2015) BindingDB Entry DOI: 10.7270/Q2T72G8M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM182733![]() (US9145408, 360) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | n/a | n/a | 1.67E+3 | n/a | n/a | 7.4 | 4 |
Purdue Pharma LP US Patent | Assay Description ORL-1 Receptor [35S]GTPγS Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like (ORL-1) (... | US Patent US9145408 (2015) BindingDB Entry DOI: 10.7270/Q2DJ5DD3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM199357![]() (US9221831, 22) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.44E+3 | n/a | n/a | 7.4 | 50 |
Purdue Pharma LP US Patent | Assay Description Functional [35S]GTPgammaS binding assays were conducted as follows. ORL-1 membrane solution was prepared by sequentially adding final concentrations ... | US Patent US9221831 (2015) BindingDB Entry DOI: 10.7270/Q2T72G8M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM199340![]() (US9221831, 4) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.92E+3 | n/a | n/a | 7.4 | 50 |
Purdue Pharma LP US Patent | Assay Description Functional [35S]GTPgammaS binding assays were conducted as follows. ORL-1 membrane solution was prepared by sequentially adding final concentrations ... | US Patent US9221831 (2015) BindingDB Entry DOI: 10.7270/Q2T72G8M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM199352![]() (US9221831, 17) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.52E+3 | n/a | n/a | 7.4 | 50 |
Purdue Pharma LP US Patent | Assay Description Functional [35S]GTPgammaS binding assays were conducted as follows. ORL-1 membrane solution was prepared by sequentially adding final concentrations ... | US Patent US9221831 (2015) BindingDB Entry DOI: 10.7270/Q2T72G8M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM199337![]() (US9221831, 1) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.10E+3 | n/a | n/a | 7.4 | 50 |
Purdue Pharma LP US Patent | Assay Description Functional [35S]GTPgammaS binding assays were conducted as follows. ORL-1 membrane solution was prepared by sequentially adding final concentrations ... | US Patent US9221831 (2015) BindingDB Entry DOI: 10.7270/Q2T72G8M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM199339![]() (US9221831, 3) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.55E+3 | n/a | n/a | 7.4 | 50 |
Purdue Pharma LP US Patent | Assay Description Functional [35S]GTPgammaS binding assays were conducted as follows. ORL-1 membrane solution was prepared by sequentially adding final concentrations ... | US Patent US9221831 (2015) BindingDB Entry DOI: 10.7270/Q2T72G8M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM199353![]() (US9221831, 18) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.89E+3 | n/a | n/a | 7.4 | 50 |
Purdue Pharma LP US Patent | Assay Description Functional [35S]GTPgammaS binding assays were conducted as follows. ORL-1 membrane solution was prepared by sequentially adding final concentrations ... | US Patent US9221831 (2015) BindingDB Entry DOI: 10.7270/Q2T72G8M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220380![]() (US9290488, ZA01) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >2.00E+4 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220385![]() (US9290488, ZA06) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >2.00E+4 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220390![]() (US9290488, ZA11) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >2.00E+4 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220388![]() (US9290488, ZA09) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >2.00E+4 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220389![]() (US9290488, ZA10) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >2.00E+4 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220382![]() (US9290488, ZA03) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >2.00E+4 | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220380![]() (US9290488, ZA01) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 0.220 | -55.1 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma LP US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM177911![]() (US9120797, 10 | US9120797, 9) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 0.260 | -54.7 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Gruenenthal GmbH US Patent | Assay Description The cyclohexane derivatives of the general formula I were investigated in a receptor binding assay with 3H-nociceptin/orphanin FQ with membranes from... | US Patent US9120797 (2015) BindingDB Entry DOI: 10.7270/Q2X065T3 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 504 total ) | Next | Last >> |